PUBLISHER: The Business Research Company | PRODUCT CODE: 1945548
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945548
A medical exoskeleton is a wearable robotic system that supports and enhances body movement, helping people with mobility impairments during rehabilitation and daily activities by improving strength, stability, and functional mobility.
The primary types of medical exoskeletons include powered exoskeletons and passive exoskeletons. Powered exoskeletons are wearable systems that utilize motors or actuators to assist or enhance user movement, offering powered support to improve mobility, support rehabilitation, or augment physical performance for different tasks. The components include hardware and software, and the mobility types are categorized as stationary and mobile. The supported extremities include lower body, upper body, and full body, with applications such as spinal cord injury, stroke, and others.
Tariffs are impacting the medical exoskeleton market by increasing the cost of imported robotic components, sensors, and control systems. Powered exoskeleton segments, particularly full-body and lower limb devices, are most impacted, with Asia-Pacific regions such as China and Japan facing higher import duties. These tariffs have led to increased product prices and slowed adoption in certain regions. On the positive side, tariffs have encouraged local manufacturing, boosted innovation in component sourcing, and supported the development of domestic exoskeleton production capabilities.
The medical exoskeleton market research report is one of a series of new reports from The Business Research Company that provides medical exoskeleton market statistics, including medical exoskeleton industry global market size, regional shares, competitors with a medical exoskeleton market share, detailed medical exoskeleton market segments, market trends and opportunities, and any further data you may need to thrive in the medical exoskeleton industry. This medical exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical exoskeleton market size has grown exponentially in recent years. It will grow from $0.53 billion in 2025 to $0.66 billion in 2026 at a compound annual growth rate (CAGR) of 25.2%. The growth in the historic period can be attributed to limited availability of powered exoskeletons, high cost of early robotic devices, low awareness of rehabilitation robotics, reliance on passive exoskeletons, fragmented healthcare infrastructure.
The medical exoskeleton market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to technological advancements in AI-assisted exoskeletons, expansion of rehabilitation centers globally, increasing investment in mobility-impaired patient care, rising integration with wearable monitoring and IoT devices, development of lightweight and ergonomic exoskeleton designs. Major trends in the forecast period include rising adoption of exoskeletons in rehabilitation centers, increasing use of lower and upper limb support devices, expansion of full-body exoskeleton applications, growing integration with wearable sensors and monitoring systems, focus on ergonomics and user comfort for daily use.
The increase in spinal cord and brain injuries is increasingly supporting the expansion of the medical exoskeleton market going forward. Spinal cord and brain injuries involve traumatic damage to the central nervous system, often resulting in substantial impairment of motor, sensory, and cognitive functions. The rise in spinal cord and brain injuries is largely associated with higher incidences of vehicular accidents, falls, sports-related injuries, and violent incidents. Medical exoskeletons assist individuals with spinal cord and brain injuries by supporting mobility and rehabilitation, enhancing physical strength, and enabling improved functional movement. For example, in October 2023, according to the World Federation of Neurology, a UK-based organization dedicated to advancing neurological research and practice, more than 40% of the global population was affected by a neurological condition, with projections indicating this burden could nearly double by 2050. As a result, the increasing incidence of spinal cord and brain injuries is contributing to the expansion of the medical exoskeleton market.
Leading companies operating in the medical exoskeleton market are focusing on integrating smart powering mechanism technologies to improve workforce efficiency and support the nursing profession amid ongoing labor shortages. A smart robotic exoskeleton is a wearable robotic system designed to enhance the physical capabilities of the human body. For example, in December 2023, German Bionic, a Germany-based automation machinery manufacturing company, launched the Apogee+ e-exoskeleton. This device is designed to assist healthcare professionals by providing dynamic lifting support and facilitating patient mobilization. It reduces up to 66 pounds (30 kg) of back strain, supporting activities such as patient transfers, medical examinations, and repositioning. The Apogee+ incorporates a safety-focused closed structure and specialized grips to mitigate physical risks, enhancing safety for both caregivers and patients. Its ergonomic design supports effective nurse-patient interaction by combining robotic assistance with human-centered engineering.
In August 2023, ReWalk Robotics Ltd., a US-based technology company, acquired AlterG, Inc. for an undisclosed amount. Through this acquisition, ReWalk sought to enhance its clinical and home rehabilitation offerings by integrating AlterG's anti-gravity systems, enabling precisely controlled, gravity-reduced movement therapy, and supporting its path toward profitability. AlterG is a US-based company that provides medical exoskeleton and rehabilitation solutions.
Major companies operating in the medical exoskeleton market are Honda, Panasonic Holdings Corporation, Parker Hannifin Corporation, Ottobock SE & Co KGaA, DIH International Limited, Fourier Intelligence, Cyberdyne Inc, GBS German Bionic Systems GmbH, Hocoma AG, Neofect, Bionic Yantra, Ekso Bionics Holdings Inc., Hexar Humancare, MediTouch, Suit X, ReWalk Robotics, Rex Bionics Ltd, Human Motion Technologies LLC, Guangzhou Yikang Medical Equipment, NextStep Robotics, Marsi Bionics, Focal Meditech, Gogoa Mobility Robots, B-Temia, Rehab-Robotics Company Limited, Roam Robotics, Bionik Laboratories Inc.
North America was the largest region in the medical exoskeleton market in 2025. The regions covered in the medical exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical exoskeleton market consists of sales of robotic exoskeletons, wearable exoskeletons, and orthotic exoskeletons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Exoskeleton Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical exoskeleton ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical exoskeleton market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.